Lori-Belle Slone is the pharmacy clinical manager and residency program
director for the PGY1 Pharmacy Residency Program at UK King's Daughters
located in Ashland, Kentucky. She co-founded and currently serves as the
management rotation preceptor in both the PGY1 and PGY2-Infectious Diseases
programs. She received her Doctor of Pharmacy degree at the University
of Kentucky College of Pharmacy in 2004. After graduation, she completed
a pharmacy practice residency at Saint Claire Regional Medical Center
in Morehead, Kentucky. She achieved board certification in pharmacotherapy
in 2007. Dr. Slone joined King’s Daughters in 2005 and has served
in a variety of roles including staffing, clinical (internal medicine
and critical care), and interim director. She currently serves on the
leadership team and a variety of committees. She is a member of the American
Society of Health System Pharmacists (ASHP). Her professional interests
include medication safety, transitions of care, patient advocacy, and
practice advancement.
Dr. Sobnosky serves as a preceptor for the infectious diseases and antimicrobial
stewardship rotations. She is the pharmacy leader for the UK King’s
Daughters Antimicrobial Stewardship Program and director for the PGY-2
Infectious Diseases Residency Program. Dr. Sobnosky received her Doctor
of Pharmacy degree from Duquesne University in 2013. After graduation,
she completed a pharmacy practice residency at Cabell Huntington Hospital
in Huntington, W.Va. Dr. Sobnosky achieved board certification in pharmacotherapy
in 2015, completed the Advanced MAD-ID Antimicrobial Stewardship Training
Program in 2016, and achieved board certification in infectious diseases
in 2020. She is a member of the American College of Clinical Pharmacy
(ACCP), American Society of Health System Pharmacists (ASHP), Lambda Kappa
Sigma (LKS) Alumni Association, Making a Difference in Infectious Diseases
(MAD-ID), and Society of Infectious Diseases Pharmacists (SIDP). She has
presented multiple posters and management case studies at national conferences.
Her professional interests include combating antimicrobial resistance,
optimizing antibiotic dosing, and tele-stewardship.
Dr. Carter received her Doctor of Pharmacy degree from Marshall University
School of Pharmacy in 2021 and completed a pharmacy practice residency
at UK King’s Daughters in 2022. After residency, Dr. Carter has
remained at King’s Daughters as a clinical staff pharmacist and
currently serves as residency program coordinator for the PGY1 and PGY2-ID
programs. She is a member of American Society of Health-System Pharmacists
(ASHP) and American Pharmacists Association (APhA). Dr. Carter’s
primary area of focus is internal medicine and she is a preceptor for
the Hospitalist and Cardiology rotations in the PGY1 residency program.
Dr. Baier serves as a clinical pharmacist and as a staffing support preceptor
for the PGY1 program. She also serves as an APPE preceptor in Geriatrics/TOC.
Jennifer received her Doctor of Pharmacy degree from the University of
Kentucky in 2000. After graduation, she served as a retail pharmacist
and PIC for Walmart 10-1139 and Sam’s Club 10-8152. She has been
employed at UK King’s Daughters since 2008. Jennifer completed her
Board Certification in Pharmacotherapy in 2024. She is also a member of
the American Society of Health Systems Pharmacists (ASHP).
Dr. Bonzo is the supervisor of the outpatient infusion center pharmacy
serving patients receiving both oncology and non-oncology infusion therapies.
He serves as a preceptor for the PGY1 Oncology elective. Dr. Bonzo received
his Bachelor of Science in Biology from the University of Kentucky in
2014 and his Doctor of Pharmacy from Marshall University in 2019. Dr.
Bonzo began his career with UK King’s Daughters in 2017 as a pharmacy
intern. He has been working in the outpatient infusion setting since 2019,
where he has participated in various roles including piloting a pharmacist-led
oral oncolytic navigator position. He is currently involved in oncology
treatment plan development with participation on the beacon subcommittee,
and participates on the UKKD Cancer Committee.
Dr. Brown received his Doctor of Pharmacy degree from the University of
Kentucky College of Pharmacy in 2014. Dr. Brown has served at UK King’s
Daughters as a clinical staff pharmacist since graduation and also as
an Antimicrobial Stewardship Pharmacist since 2018. Dr. Brown recently
completed an Antimicrobial Stewardship Certificate with SIDP in 2023.
He serves as a preceptor for the PGY1 and PGY2-ID residency programs.
Dr. Bussa currently serves as a Pharmacy IV admix supervisor at UK King’s
Daughters and has served in various roles in the twelve years she has
been with the hospital including ambulatory care, critical care, and institutional
pharmacy. She also served as an antimicrobial stewardship pharmacist and
clinical pharmacist for several years. She received her Doctor of Pharmacy
from the Lloyd L. Gregory School of Pharmacy at Palm Beach Atlantic University in 2007.
She currently serves as a preceptor for the PGY1 residents in the King's
Daughters residency program and has precepted APPE students for the geriatric
and institutional rotations. Prior to this position, she was a clinical
microbiologist at Integrated Regional Laboratories from 2001 to 2007 and
still maintains licensure as a clinical laboratory scientist in microbiology
and has received recognition awards from the laboratory for teamwork,
leadership, and outstanding performance in handling and assisting with
the anthrax cultures in 2001. She also served as a lead role and trained
other clinical microbiologists during this time. She is an active leader
in several local organizations in her community and recently served as
a faculty member for American Society of Health-System Pharmacists (ASHP)
including presenting at the 2023 Summer Meeting Exhibition in Baltimore.
She is currently board certified in sterile compounding. Her primary focus
is to lead efforts hospital wide in quality improvement, hospital wide
education, regulatory compliance, and patient safety with a focus on handling
of hazardous drugs and sterile compounding.
Dr. Dillon is a clinical staff pharmacist for UK King’s Daughters.
She received her Doctor of Pharmacy and Masters of Business Administration
with a concentration in Healthcare Administration from Marshall University in 2022.
Dr. Dillon completed the ASHP Medication Safety Certificate in August of
2024. Dr. Dillon is also a member of the American Society of Health System
Pharmacists (ASHP). She currently serves as a preceptor for the staffing
portion of the PGY1 residency program.
Dr. Fletcher serves as a preceptor for the PGY1 and PGY2 residents. Dr.
Fletcher received his Bachelor of Science in Chemistry from Morehead State
University in 2017 and his Doctor of Pharmacy from the University of Charleston
School of Pharmacy in 2018. Dr. Fletcher began his career with UK King's
Daughters in 2015 as a pharmacy intern. Since then, he has worked as a
staff pharmacist and clinical pharmacist in internal medicine and critical
care. He is also a member of the critical care committee.
Dr. Gross is the transitions of care clinical pharmacist at UK King’s
Daughters and serves as a preceptor for the PGY1 and PGY2-ID programs.
Dr. Gross received her Doctor of Pharmacy degree from the University of
Charleston in 2019. After graduation, she completed a pharmacy practice
residency at King’s Daughters Medical Center in conjunction with
Marshall University School of Pharmacy. Dr. Gross completed a second pharmacy
residency in geriatrics in 2021 at the Charleston Area Medical Center
in Charleston, W.Va. She has presentd posters at several pharmacy conferences
and was able to publish her research in the
Journal of Trauma Nursing in 2021 regarding medication-associated fall risk in a trauma population.
Dr. Harmon received her doctor of pharmacy degree from the University of
Charleston in 2021. Dr. Harmon completed a PGY-1 residency at UK King’s
Daughters from 2021-2022. After completing residency, she accepted a position
as an emergency medicine clinical pharmacist at King’s Daughters
where she now serves as one of four preceptors for PGY-1 residents. She
completed her board certification in pharmacotherapy in 2023. Her future
goals include becoming board certified in emergency medicine.
Dr. Hieneman serves as pharmacy operations supervisor at UK King’s
Daughters in Ashland, Ky. Dr. Hieneman received her Doctor of Pharmacy
degree from the University of Kentucky in 2007. Dr. Hieneman has been
employed at King's Daughters in various roles since graduation including
staffing, clinical, ambulatory care and oncology infusion pharmacy. Dr.
Hieneman has been in her operations role since 2018. Dr. Hieneman is an
active member of American Society of Health-System Pharmacists (ASHP).
Dr. Hieneman’s primary areas of focus are the distributive functions
of the inpatient pharmacy with an emphasis on process improvement and
pharmacy automation. Dr. Hieneman holds a Pyxis ES System Manager Certificate
and oversees automated dispensing cabinets throughout the organization.
Dr. Hieneman serves as a PGY-1 resident preceptor for the staffing component
of the residency program and is involved with the resident onboarding
process with emphasis on EHR training.
Dr. Keeton is an Assistant Clinical Professor with the University of Kentucky
College of Pharmacy where she serves as the Ashland Clinical Education
Coordinator. She also serves as an infectious diseases clinical pharmacist
and PGY2 residency preceptor at UK King’s Daughters. In addition,
she is a voting member of the Kentucky HIV Planning and Advisory Council
(KHPAC). In her prior role, she precepted PGY1 residents and students
for the internal medicine and elective cardiology rotations. Dr. Keeton
received her Doctor of Pharmacy degree from the University of Kentucky
in 1999. After graduation, she completed an Antimicrobial Stewardship
Certification with SIDP and MAD-ID, an ASHP Critical Care Traineeship,
and an Opioid Stewardship Certification. Dr. Keeton achieved board certification
in pharmacotherapy in 2007. She is currently a member of ACCP, KPhA, MAD-ID
and SIDP. Dr. Keeton has previously been employed at Kroger Pharmacy,
Rite Aid Pharmacy, Omnicare, and the Federal Bureau of Prisons and is
a former co-owner of an independent retail/specialty hybrid pharmacy in
Louisville, Ky.
Dr. Keslar decided to pursue pharmacy after seeing the impact pharmacists
made on one of her family members. She graduated from Ohio Northern University
with High Distinction in 2002. Following graduation, Dr. Keslar practiced
in retail, long-term care, and inpatient pharmacy. She has been a part
of the KDMC team since 2007 in a variety of roles and currently serves
as the compliance coordinator and co-chair of the Medication Safety Committee
as well as serves as a preceptor for the PGY1 and PGY2-ID programs. Dr.
Keslar completed the ASHP Medication Safety Certificate in September 2022.
Dr. Keslar says she is most passionate about keeping patients safe while
in the hospital and preventing drug diversion. When not at work, she enjoys
spending time with family, traveling and camping.
Dr. Large serves as a PGY1 resident preceptor for the Advanced Illness
Management/Pain Management and Substance Use Disorder Rotations at UK
King's Daughters. Dr. Large received her B.S. in Pharmacy from The Ohio
State University in 1998 and completed a non-traditional PharmD at University
of Cincinnati in 2000. Dr. Large also completed ASHP Pain Management Certificate
Program in June 2020. Dr. Large serves as co-chair on KDMC’s Opioid
Stewardship/Pain Team Committee and is a member of the KDMC Medication
for Opioid Use Disorder (MOUD) committee. Dr. Large has worked as clinical
pharmacist at KDMC since relocating from Cincinnati area in 2011 where
she previously worked for 11 years as clinical pharmacy coordinator, clinical
pharmacist, and staff pharmacist within the UC Health organization.
Dr. Luster received her doctorate of pharmacy from the University of Charleston
in 2023. Dr. Luster completed a PGY-1 residency at UK King’s Daughters
in 2024. After completing residency, she accepted a position as a clinical
staff pharmacist at UK King’s Daughters. She now serves as a supporting
preceptor in critical care and internal medicine for PGY-1 residents.
Her future goals include becoming board certified in critical care and
building a surgical pharmacy service.
Dr. Meakin serves as a clinical pharmacist at UK King's Daughters and preceptor
for the PGY1 and PGY2-ID programs. She received her Bachelor of Science
in chemistry from Ohio University in 2015 and her Doctor of Pharmacy from
Marshall University in 2020. After graduation, she completed a PGY1 residency
at Charleston Area Medical Center. Her professional interests include
antimicrobial stewardship and infectious diseases.
Dr. Murphy received her PharmD from Auburn University Harrison School of
Pharmacy. After 6 years of staff pharmacy practice, she completed her
PGY-1 and PGY-2 Critical Care residency program at Novant Health Forsyth
Medical Center in Winston-Salem, N.C. Dr. Murphy served as an EM pharmacist
and preceptor at Cabell Huntington Hospital in West Virginia and later
at the University of Virginia in Charlottesville, Va., where she also
served as a clinical assistant professor at Virginia Commonwealth University.
Her clinical interests include neurology, cardiology, and toxicology.
Dr. Nowling serves as a preceptor for the emergency medicine rotation.
He received his Doctor of Pharmacy from Roseman University of Health Sciences
in South Jordan, UT in 2019. After graduation, he completed a pharmacy
practice residency at Charleston Area Medical Center in Charleston, W.Va.
He then completed a PGY2 residency in critical care at Charleston Area
Medical Center. He has been employed at UK King’s Daughters since
2021. Dr. Nowling is a member of the Society of Critical Care Medicine
(SCCM) and American College of Clinical Pharmacy (ACCP). He is also achieved
board certification in critical care pharmacy (BCCCP). His professional
interests include anticoagulation reversal, sedation management, and trauma.
Dr. O’Bryan serves as manager of Outpatient Pharmacy Services at
UK King’s Daughters. Dr. O’Bryan received his Doctor of Pharmacy
degree in 2008 from Shenandoah University Bernard J. Dunn School of Pharmacy,
as well as his Bachelor of Science in Chemistry from Morehead State University
in 2004. Dr. O’Bryan is currently in the Master of Business Administration
Health Systems Management Program at Morehead State University. Following
graduation, he served as a clinical pharmacist and then pharmacy clinical
Manager at Highlands Regional Medical Center in Prestonsburg, Ky. Dr.
O’Bryan joined KDMC in 2019 as the lead oncology pharmacist and
infusion center pharmacy coordinator. Currently Dr. O’Bryan manages
the outpatient pharmacy departments, including the retail pharmacy, infusion
center and oncology pharmacy, and ambulatory care Pharmacy. Dr. O’Bryan
serves as a preceptor for the oncology elective rotation in the PGY1 program
and OPAT rotation for the PGY2-ID program.
Dr. Osborne is a 2022 graduate of the University of Kentucky College of
Pharmacy. He also received his Master of Business Administration from
the Gatton College of Business in 2022. Dr. Osborne completed his PGY-1
and PGY-2 in Infectious Diseases at UK King's Daughters Medical Center.
He is an active member of multiple state and national Infectious Diseases
organizations and is a member of the Antimicrobial Stewardship team at
KDMC. Dr. Osborne's research interests include improving Hepatitis C treatment
rates, HIV medication management, and building an Outpatient Parenteral
Antimicrobial Therapy (OPAT) program.
Dr. Perkins serves as supervisor of Ambulatory Care Pharmacy Services at
UK King’s Daughters. Dr. Perkins received his Doctor of Pharmacy
degree in 1999 from Midwestern University Chicago College of Pharmacy,
as well as his Bachelor of Pharmacy Science from Midwestern University
Chicago College of Pharmacy in 1998. Following graduation, he worked retail
pharmacy at Rite Aid, Our Lady of Bellefonte Hospital and Kroger Pharmacy,
then as a staff/clinical pharmacist at Our Lady of Bellefonte Hospital.
Dr. Perkins joined KDMC in 2006 as a staff/clinical pharmacist. Currently
Dr. Perkins is the supervisor of Ambulatory Care Pharmacy Services and
serves as a preceptor for the ambulatory selective and elective rotation
in the PGY1 program.
Chris Raich, PharmD |
chris.raich@kdmc.kdhs.us Dr. Raich serves as a clinical pharmacist and residency preceptor for critical
care for UK King’s Daughters at the medical center in Ashland. Dr.
Raich received his Bachelor of Science in Pharmacy degree and Doctor of
Pharmacy degree from West Virginia University in 1997 and 1998, respectively.
After graduation, he completed a pharmacy practice residency at the University
of Michigan Health System in Ann Arbor, MI. in 1999. Dr. Raich has previously
been employed as a staff pharmacist at the University of Michigan Health
System in Ann Arbor. Dr. Raich achieved board certification in pharmacotherapy
in 2015. Dr. Raich has been employed at King’s Daughters since 1999.
He serves on the critical care council and code blue committee. Dr. Raich
is a member of the American Society of Health System Pharmacists (ASHP).
Dr. Riley serves as a clinical associate professor, director of residency
programs and director of the Center for Pharmacy Education at Marshall
University School of Pharmacy. Dr. Riley received her doctor of pharmacy
degree from the University of Kentucky in 2010. After graduation, she
completed a pharmacy practice residency at Cabell Huntington Hospital
in Huntington, W.Va., and Masters in Pharmacy with an emphasis in Clinical
Toxicology from the University of Florida in 2015. Dr. Riley achieved
board certification in pharmacotherapy in 2012. Dr. Riley has previously
been employed at King’s Daughters Medical Center, and as an Assistant
Professor/Emergency Medicine Clinical Specialist with the University of
Charleston and Southern Ohio Medical Center.
Dr. Riley is an active member of many local and national organizations.
She is a member of the American Society of Health-System Pharmacists (ASHP),
and is a Past-President and Education Chair of the West Virginia Society
of Health-System Pharmacists (WVSHP).
Dr. Riley’s primary area of research focus is tackling the opioid
epidemic through both primary and secondary prevention efforts. She has
received funding from SAMSHA as part of the MUSBIRT team and from the
West Virginia Clinical and Translational Science Institute.
Dr. Rist received her Doctor of Pharmacy from Marshall University School
of Pharmacy in 2019. She began her career at UK King’s Daughters
in 2015 as a pharmacy intern. After graduation, she worked for a health
system in eastern Kentucky where she worked in various settings including
inpatient staffing, inpatient clinical service, warfarin clinic, and oncology
infusion clinic. Dr. Rist returned to UK King’s Daughters in 2021
as a clinical staff pharmacist. She serves as a primary preceptor for
the longitudinal staffing rotation and a supporting preceptor for the
internal medicine rotation for the PGY1 program.
Dr. Romanello serves as the executive director of Pharmacy Services at
UK King’s Daughters. Dr. Romanello received his Doctor of Pharmacy
degree from the University of Charleston and Master’s Degree in
Business Administration with Healthcare Concentration from Ohio University.
After graduation, he served as a health system clinical pharmacist before
transitioning to the US Department of Veterans Affairs, Chillicothe (Ohio)
VAMC, where he served as a PACT clinical pharmacy specialist and associate
chief of pharmacy. He has been employed with King’s Daughters since 2021.
Dr. Stevens serves as a primary preceptor for the internal medicine/hospitalist
rotation. She received her bachelor of science in biology from Georgetown
College in 2010 and her Doctor of Pharmacy from the University of Kentucky
in 2014. After graduation, she completed a pharmacy practice residency
at Baptist Health Madisonville in Madisonville, Ky., from 2014-2015. She
has been employed at UK King's Daughters since 2015.
She completed her board certification in pharmacotherapy in 2021. In 2023,
Dr. Stevens completed the ASHP Diabetes Management Certificate. She is
a co-chair of the Diabetes Management Committee and the pharmacy representative
for the BSTOP (Bariatric Surgery Targeting Opioid Prescriptions) Committee.
Dr. Stevens is also a member of the American Society of Health System
Pharmacists (ASHP).
Dr. Wine received her Doctor of Pharmacy from the University of Charleston
School of Pharmacy in 2022. She completed her PGY-1 pharmacy residency
at UK King's Daughters in 2023 and accepted a position as a clinical staff
pharmacist at King’s Daughters. Dr. Wine is a supporting preceptor
for the PGY-1 program for the transitions of care and internal medicine
rotations. Her professional interests include ambulatory care and transitions of care.